Any current/future capex/capital investment/strategic investment?

Meghnagar Capacity Expansion: Addition of 165,000 MTPA of NPK/DAP Complex and 99,000 MTPA of Sulphuric Acid capacity. Project Cost: ₹142 crore, with ₹4 crore already spent as of Q1 FY26. Status: Civil work commenced; orders for plant & machinery released; approvals applied. Commercial Production Target: March 2026. Funding: ₹75 crore through debt, remaining through internal accruals. Expected Growth: Initial 20%-25% growth post-expansion; aim for 80% capacity utilization within 3 years. New Product Launch: Fortified SSP and Urea SSP launched; focus on farmer-centric product innovation. Strateg

Future growth expectations in sales/revenue/volumes?

The company expects a revenue growth from ₹1,358 crore (FY25) to around ₹1,500 crore in FY26. Sales volume guidance for FY26 is approximately 2,40,000 MT of NPK and 1,15,000 MT of SSP. With the upcoming 50% capacity expansion (165,000 MT), initial growth of 20%-25% post-plant operation is expected. Capacity utilization is targeted at about 81% currently, aiming to maintain or improve this. Post-expansion, capacity utilization for the new plant aims to reach 80% within three years (FY28). Market demand remains strong with good monsoon and fertilizer shortages in India, supporting sust

Future growth expectations in earnings/operating earnings/profits/EPS?

Revenue is expected to reach around ₹1,500 crore in FY26, up from ₹1,358 crore in the previous year. EBITDA margins are anticipated to remain stable around 16-17%, supported by operational efficiencies and backward integration. PAT showed strong growth of 86.6% YoY in Q1 FY26 and is expected to sustain upward momentum. The new plant coming online by March 2026 will initially add 20-25% growth in capacity and utilization is expected to gradually scale to ~80% in 3 years, driving volume and profit growth. EPS rose significantly to ₹4.95 in Q1 FY26 and is expected to improve with higher c

Any current/future new fundraising through debt or equity?

The company plans to incur a CAPEX of ₹142 crore for capacity expansion at Meghnagar, covering NPK/DAP complex and Sulphuric Acid capacity. Funding for this CAPEX is planned through a mix of debt and internal accruals. Specifically, approximately ₹75 crore will be raised through debt. The remaining amount for the CAPEX will be funded from internal accruals. As of Q1 FY26, around ₹4 crore has already been spent on the project. There is no mention of any current or future equity fundraising in the transcript.

IN US

Sale is live|00:00:00left today

Krishana Phoschem LtdQ2 FY25Fertilizers & Agrochemicals

Krishana Phoschem Ltd Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹727P/E: 22.5Market Cap: ₹4.1K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→The company expects a revenue growth from ₹1,358 crore (FY25) to around ₹1,500 crore in FY26.
→Sales volume guidance for FY26 is approximately 2,40,000 MT of NPK and 1,15,000 MT of SSP.
→With the upcoming 50% capacity expansion (165,000 MT), initial growth of 20%-25% post-plant operation is expected.
→Capacity utilization is targeted at about 81% currently, aiming to maintain or improve this.
→Post-expansion, capacity utilization for the new plant aims to reach 80% within three years (FY28).
→Market demand remains strong with good monsoon and fertilizer shortages in India, supporting sustained sales growth.
→The company expects to sustain EBITDA margins around 16%-17%.
→New product launches and backward integration are expected to support growth and margin improvement.

Margin guidance

Category 3

→Revenue is expected to reach around ₹1,500 crore in FY26, up from ₹1,358 crore in the previous year.
→EBITDA margins are anticipated to remain stable around 16-17%, supported by operational efficiencies and backward integration.
→PAT showed strong growth of 86.6% YoY in Q1 FY26 and is expected to sustain upward momentum.
→The new plant coming online by March 2026 will initially add 20-25% growth in capacity and utilization is expected to gradually scale to ~80% in 3 years, driving volume and profit growth.
→EPS rose significantly to ₹4.95 in Q1 FY26 and is expected to improve with higher capacity utilization and operational leverage.
→The company aims to maintain 2-3x asset turnover ratios but notes limited scope for substantial improvement due to the bulk raw material procurement cycle.
→Overall, sustainable growth, margin stability, and increasing profitability are anticipated in medium term.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes

→The company plans to incur a CAPEX of ₹142 crore for capacity expansion at Meghnagar, covering NPK/DAP complex and Sulphuric Acid capacity.
→Funding for this CAPEX is planned through a mix of debt and internal accruals.
→Specifically, approximately ₹75 crore will be raised through debt.
→The remaining amount for the CAPEX will be funded from internal accruals.
→As of Q1 FY26, around ₹4 crore has already been spent on the project.
→There is no mention of any current or future equity fundraising in the transcript.

Order book

The transcript does not explicitly mention the current or expected order book or pending orders for Krishana Phoschem Limited. However, relevant insights include: - The company is witnessing strong seasonal demand, particularly in the Kharif season. - Supply-side tightness due to raw material shortages is expected to persist through the year. - Production capacity is currently utilized at around 81%, with plans to ramp up utilization post new plant commissioning. - The new Meghnagar expansion project, adding 165,000 MTPA NPK/DAP and 99,000 MTPA Sulphuric Acid capacity, targeting commercial production by March 2026, underlines upcoming order fulfillment capacity. - Marketing and sales channels are stable without constraints on demand; the company is confident about selling all produced volumes. - The company aims for around 20% growth initially post-new plant commissioning and scaling up to ~80% utilization within three years. No direct data on order book or pending orders is provided.

Capex plans

Yes

→Meghnagar Capacity Expansion: Addition of 165,000 MTPA of NPK/DAP Complex and 99,000 MTPA of Sulphuric Acid capacity.
→Project Cost: ₹142 crore, with ₹4 crore already spent as of Q1 FY26.
→Status: Civil work commenced; orders for plant & machinery released; approvals applied.
→Commercial Production Target: March 2026.
→Funding: ₹75 crore through debt, remaining through internal accruals.
→Expected Growth: Initial 20%-25% growth post-expansion; aim for 80% capacity utilization within 3 years.
→New Product Launch: Fortified SSP and Urea SSP launched; focus on farmer-centric product innovation.
→Strategic Focus: Evaluating new growth opportunities to scale and diversify operations.

How does Krishana Phoschem Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1Krishana Phoschem Ltd

Rev 2Mar 3

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like Krishana Phoschem Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio